Health economics of cardiovascular disease: Defining the research agenda

Keith C. Ferdinand; Diane Orenstein; Yuling Hong; Joann G. Journigan; Justin Trogdon; Jennifer Bowman; Armineh Zohrabian; Meredith Kilgore; Alexander White; Ali Mokdad; Terry F. Pechacek; Ron Z. Goetzel; Darwin R. Labarthe; Gary A. Puckrein; Eric Finkelstein; Guijing Wang; Molly E. French; Viola Vaccarino

doi:10.1016/j.cvdpc.2011.05.001

Health economics of cardiovascular disease: Defining the research agenda

Keith C. Ferdinand^*, Diane Orenstein, Yuling Hong, Joann G. Journigan, Justin Trogdon, Jennifer Bowman, Armineh Zohrabian, Meredith Kilgore, Alexander White, Ali Mokdad, Terry F. Pechacek, Ron Z. Goetzel, Darwin R. Labarthe, Gary A. Puckrein, Eric Finkelstein, Guijing Wang, Molly E. French, Viola Vaccarino

^*Corresponding author for this work

Preventive Medicine

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Background: When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data. Methods and Results: The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda. Conclusions: Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.

Original language	English (US)
Pages (from-to)	91-100
Number of pages	10
Journal	CVD Prevention and Control
Volume	6
Issue number	3
DOIs	https://doi.org/10.1016/j.cvdpc.2011.05.001
State	Published - Sep 2011

Funding

Funding for this research was provided by the Centers for Disease Control and Prevention (CDC), Division for Heart Disease and Stroke Prevention, to the Policy Research Implementation Group of the National Forum for Heart Disease and Stroke Prevention.

Keywords

Cardiovascular disease
Disparities
Economic modeling
Health economics
Surveillance/evaluation

ASJC Scopus subject areas

Epidemiology
Community and Home Care
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.cvdpc.2011.05.001

Cite this

Ferdinand, K. C., Orenstein, D., Hong, Y., Journigan, J. G., Trogdon, J., Bowman, J., Zohrabian, A., Kilgore, M., White, A., Mokdad, A., Pechacek, T. F., Goetzel, R. Z., Labarthe, D. R., Puckrein, G. A., Finkelstein, E., Wang, G., French, M. E., & Vaccarino, V. (2011). Health economics of cardiovascular disease: Defining the research agenda. CVD Prevention and Control, 6(3), 91-100. https://doi.org/10.1016/j.cvdpc.2011.05.001

@article{91077cf414cd4e63abd8d7f6a40ad226,

title = "Health economics of cardiovascular disease: Defining the research agenda",

abstract = "Background: When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data. Methods and Results: The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda. Conclusions: Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.",

keywords = "Cardiovascular disease, Disparities, Economic modeling, Health economics, Surveillance/evaluation",

author = "Ferdinand, {Keith C.} and Diane Orenstein and Yuling Hong and Journigan, {Joann G.} and Justin Trogdon and Jennifer Bowman and Armineh Zohrabian and Meredith Kilgore and Alexander White and Ali Mokdad and Pechacek, {Terry F.} and Goetzel, {Ron Z.} and Labarthe, {Darwin R.} and Puckrein, {Gary A.} and Eric Finkelstein and Guijing Wang and French, {Molly E.} and Viola Vaccarino",

note = "Funding Information: Funding for this research was provided by the Centers for Disease Control and Prevention (CDC), Division for Heart Disease and Stroke Prevention, to the Policy Research Implementation Group of the National Forum for Heart Disease and Stroke Prevention. ",

year = "2011",

month = sep,

doi = "10.1016/j.cvdpc.2011.05.001",

language = "English (US)",

volume = "6",

pages = "91--100",

journal = "CVD Prevention and Control",

issn = "1875-4570",

publisher = "Elsevier Science & Technology",

number = "3",

}

Ferdinand, KC, Orenstein, D, Hong, Y, Journigan, JG, Trogdon, J, Bowman, J, Zohrabian, A, Kilgore, M, White, A, Mokdad, A, Pechacek, TF, Goetzel, RZ, Labarthe, DR, Puckrein, GA, Finkelstein, E, Wang, G, French, ME & Vaccarino, V 2011, 'Health economics of cardiovascular disease: Defining the research agenda', CVD Prevention and Control, vol. 6, no. 3, pp. 91-100. https://doi.org/10.1016/j.cvdpc.2011.05.001

TY - JOUR

T1 - Health economics of cardiovascular disease

T2 - Defining the research agenda

AU - Ferdinand, Keith C.

AU - Orenstein, Diane

AU - Hong, Yuling

AU - Journigan, Joann G.

AU - Trogdon, Justin

AU - Bowman, Jennifer

AU - Zohrabian, Armineh

AU - Kilgore, Meredith

AU - White, Alexander

AU - Mokdad, Ali

AU - Pechacek, Terry F.

AU - Goetzel, Ron Z.

AU - Labarthe, Darwin R.

AU - Puckrein, Gary A.

AU - Finkelstein, Eric

AU - Wang, Guijing

AU - French, Molly E.

AU - Vaccarino, Viola

N1 - Funding Information: Funding for this research was provided by the Centers for Disease Control and Prevention (CDC), Division for Heart Disease and Stroke Prevention, to the Policy Research Implementation Group of the National Forum for Heart Disease and Stroke Prevention.

PY - 2011/9

Y1 - 2011/9

N2 - Background: When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data. Methods and Results: The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda. Conclusions: Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.

AB - Background: When allocating limited resources, public and private sector leaders in health policy consider both the health and economic value of new measures for cardiovascular disease (CVD) prevention. The ability to develop and prioritize policy measures is hindered by important gaps in health economics data. Methods and Results: The Policy Research Implementation Group (PRIG) of the National Forum for Heart Disease and Stroke Prevention convened a symposium to develop priorities for research on the economics of CVD primary prevention and elimination of CVD disparities. Suggested top opportunities include expanded CVD surveillance, advances in evaluation and economic modeling of primary prevention, and use of behavioral economics to identify new prevention strategies. Enhanced policy, funding, and leadership support are vital to realizing this research agenda. Conclusions: Targeted research on the health and economic value of CVD prevention, especially to eliminate CVD disparities, would bolster the justification for increased investment in cardiovascular health.

KW - Cardiovascular disease

KW - Disparities

KW - Economic modeling

KW - Health economics

KW - Surveillance/evaluation

UR - http://www.scopus.com/inward/record.url?scp=79960259681&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960259681&partnerID=8YFLogxK

U2 - 10.1016/j.cvdpc.2011.05.001

DO - 10.1016/j.cvdpc.2011.05.001

M3 - Article

AN - SCOPUS:79960259681

SN - 1875-4570

VL - 6

SP - 91

EP - 100

JO - CVD Prevention and Control

JF - CVD Prevention and Control

IS - 3

ER -

Health economics of cardiovascular disease: Defining the research agenda

Abstract

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this